Let's break down what sets Codan and Pro Medicus apart when it comes to value, growth, and recent momentum.
Codan is a global technology player, best known for high-tech communications, metal detection, and mining solutions. Through segments like Codan Communications, Minelab, Minetec, and Defence Electronics, the company serves government, military, and commercial customers in dozens of countries. According to its company profile, Codan controls its own products end-to-end, with manufacturing plants in Australia and Malaysia, and a sales footprint concentrated in North America.
What stands out for Codan right now is just how quickly it's compounded shareholder value. The company's P/E ratio is on the higher side at 51.03, suggesting it's priced as a growth stock with high expectations. A dividend yield of 0.99% won't turn heads for income buffs, but it's at least ahead of most tech or high-growth names.
Pro Medicus sits at the cutting edge of digital healthcare, supplying advanced radiology and medical imaging systems across the globe. As per its most recent public description, most Pro Medicus's success story has played out in the US, where many hospitals have adopted its technology.
The market cap, at $17.68 billion, puts Pro Medicus in a different league to Codan.
Codan's share price moved from $43.48 on 19 August 2026 up to $48.59 on 17 September 2026, a gain of around 12%.
Its shares fell from $198.85 on 19 August 2026 to $169.22 on 17 September 2026 — a drop of about 15%.